TAO Digital Solutions Acquires Software Competitiveness International, Expanding European Footprint
Advances TAO’s International Growth Strategy by Strengthening Global Delivery Capabilities in Europe Expands Combined Company’s Capabilities in Automotive, Industrial,... Read more.
RCAT INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces That Red Cat Holdings, Inc. Investors With Substantial Losses Have Opportunity to Lead Class Action Lawsuit
SAN DIEGO–(BUSINESS WIRE)–The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Red Cat Holdings, Inc. (NASDAQ:... Read more.
Bruker Launches New timsUltra AIP System with Further Enhanced, Extreme Sensitivity for Single-Cell Proteomics, FNA Biopsy Immunopeptidomics and Metaproteomics
Breakthrough Athena Ion Processor (AIP) delivers up to 35% more peptide and 20% more protein identifications for highest sensitivity proteomics BALTIMORE–(BUSINESS... Read more.
Acuren Corporation Announces Upcoming Participation in the Baird 2025 Global Consumer, Technology & Services Conference
TOMBALL, Texas–(BUSINESS WIRE)–Acuren Corporation (NYSE: TIC) (the “Company” or “Acuren”), a leading provider of critical asset integrity services,... Read more.
SCIEX Sets a New Standard in Accurate Mass Quantitation With the ZenoTOF 8600 System and New Software Collaborations
MARLBOROUGH, Mass.–(BUSINESS WIRE)–#ZenoTOF–At ASMS 2025, SCIEX, a global leader in life science analytical technologies and operating company... Read more.
Forward Air Shareholders Recommended to Vote AGAINST Three Unfit Legacy Directors at 2025 Annual Meeting by ISS
ISS Concludes Chairman George Mayes, Jr., Director Javier Polit and Director Laurie Tucker Presided Over Destructive Decision-Making That Contributed to an Enormous... Read more.
KalVista Pharmaceuticals Medical Congress Presentations Highlight Potential of Sebetralstat to Redefine Hereditary Angioedema Management
–Attack progression halted in median 19.8 minutes after treatment with sebetralstat in both KONFIDENT and KONFIDENT-S trials– –Sebetralstat data demonstrated... Read more.
ImmunAbs Announces FDA Phase 2 IND Approval of IM-101, a Novel Complement C5 Inhibitor, for Treatment of Myasthenia Gravis
SEOUL, South Korea–(BUSINESS WIRE)–ImmunAbs Inc., a clinical-stage biotech specializing in developing antibody therapeutics, today announced that the... Read more.
Broadstone Net Lease Provides an Update on Recent Business Activity and Participation at Nareit’s REITweek 2025 Annual Conference
VICTOR, N.Y.–(BUSINESS WIRE)–Broadstone Net Lease, Inc. (NYSE: BNL) (“Broadstone,” “BNL,” the “Company,” “we,” “our,” or “us”),... Read more.
Antares Closes $1.2 Billion Private Credit Continuation Vehicle Led by Ares Management
CHICAGO & NEW YORK–(BUSINESS WIRE)–Antares Capital and Ares Management Corporation (“Ares”) (NYSE: ARES) today announced the closing of Antares’... Read more.